SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 88.62 |
| Enterprise Value ($M) | -4.23 |
| Book Value ($M) | 144.12 |
| Book Value / Share | 6.93 |
| Price / Book | 0.61 |
| NCAV ($M) | 70.82 |
| NCAV / Share | 3.40 |
| Price / NCAV | 1.25 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.43 |
| Return on Assets (ROA) | -0.35 |
| Return on Equity (ROE) | -0.52 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 5.82 |
| Current Ratio | 5.82 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 161.08 |
| Assets | 234.38 |
| Liabilities | 90.26 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Venrock Healthcare Capital Partners III, L.P. | 0.00 | -100.00 | |
| 13G | Rush Ryan Bradford | 5.10 | ||
| 13G/A | Vivo Opportunity Fund Holdings, L.P. | 1.10 | -98.54 | |
| 13G/A | Commodore Capital Lp | 0.00 | -100.00 | |
| 13G/A | Logos Global Management LP | 2.00 | -97.22 | |
| 13G/A | Fmr Llc | 1.13 | -96.17 | |
| 13G | BlackRock, Inc. | 7.20 | 0.00 | |
| 13G/A | Morgan Stanley | 0.40 | -98.47 | |
| 13G | Franklin Resources Inc | 8.50 | ||
| 13G | Stern Augustus | 5.37 | ||
| 13G | Principia Wealth Advisory, LLC | 5.07 | ||
| 13G/A | BML Investment Partners, L.P. | 10.60 | 93.37 | |
| 13D/A | Versant Ventures IV, LLC | 2.40 | -90.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 62,780 | 141,903 | 44.24 | |
| 43,948 | 143,868 | 30.55 | |
| 87,633 | 247,475 | 35.41 | |
| 35,407 | 157,387 | 22.50 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ACXP – Acurx Pharmaceuticals, Inc. | ADIL – Adial Pharmaceuticals, Inc. |
| ADTX – Aditxt, Inc. | AGEN – Agenus Inc. |
| AIMD – Ainos, Inc. |
Financial data and stock pages provided by
Fintel.io